StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Ashish Bahety, Profitmart Securities

BUYGlenmark Pharmaceuticals

byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred Intraday)27 Aug 2026, 9:27 am ISTvia CNBC Awaaz.

Entry₹2,475.4Inferred
Target₹2,520
Total upside +1.80% (call closed)
Stop loss₹2,430-1.83% risk
At expiry₹2,458.927 Aug 2026, 3:05 pm
Expired-0.67%
Follow Ashish Bahety for new calls(14% target hit, 163 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 3 active Intraday calls on GLENMARKSee 17 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Aug 2026
2 supporting0 opposing
Supports the BUY call (2)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·27 Aug · today

Glenmark Pharmaceuticals Inc., USA has launched a new Calcium Gluconate Injection product in various strengths and vial sizes.

BSE · Company Update·21 Aug · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.